Tom Frohlich - Chief Executive Officer, Director at Jade Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
JBIO on Nasdaq
All Insider Reports
All Insider Reports

Tom Frohlich - trading volume in the past year for Jade Biosciences, Inc.

Holdings reported by Tom Frohlich for Jade Biosciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 86,331 $1,196,547 $13.86 12 Feb 2026 Direct
Stock Option (Right to Buy) 472,500 12 Feb 2026 Direct Common Stock

Transactions reported by Tom Frohlich for Jade Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.